Press Release
CREMER OLEO has become the holder of the first CEP ever granted for a Medium-Chain Triglyceride (MIGLYOL® 812 N).
CREMER OLEO has gathered its activities for the pharmaceutical industry under the roof of CREMER Health, with a strong commitment to quality leadership in Oleoceuticals.
Our pharmaceutical excipients for topical, oral and rectal applications as well as our oleo-chemical based active pharmaceutical ingredients for enteral and parenteral applications have been enjoying a good reputation for decades.
Our strict adherence to quality is underpinned and rewarded with the repeated granting of an EU GMP-certificate as well as the availability of several regulatory documentations (US DMFs / CEP).
